Revised SPC: Solu-Cortef (hydrocortisone sodium succinate)

SPC has been updated to warn that hypertrophic cardiomyopathy has been reported after administration of hydrocortisone to prematurely born infants, therefore appropriate diagnostic evaluation and monitoring of cardiac function and structure should be performed.

Source:

electronic Medicines compendium